Journals / Anadolu Kardiyoloji Dergisi / 2010 / Cilt: 10 - Sayı: 5

Mechanisms underlying obesity associated oxidative stress: The role of leptin and adiponectin

Obezite ile ilişkili oksidatif stresin altında yatan mekanizmalar: Leptin ve adiponektinin rolü

Pages
397–399
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KILIÇ, T. (2022). Mechanisms underlying obesity associated oxidative stress: The role of leptin and adiponectin. Anadolu Kardiyoloji Dergisi, Cilt: 10 - Sayı: 5, 397–399. https://ajindex.com/articles/436739

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. WHO Consultation on obesity. Obesity: preventing and managing the global epidemic. WHO Tech Rep Series no 894. Geneva, Switzerland: World Health Organization; 2000
  2. Musaad S, Haynes EN. Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev 2007; 29: 98-114
  3. Higdon JV, Frei B. Obesity and oxidative stress: a direct link to CVD? Arterioscler Thromb Vasc Biol 2003; 23: 365-7
  4. Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009; 47: 372-81
  5. Khan NI, Naz L, Yasmeen G. Obesity: an independent risk factor for systemic oxidative stress. Pak J Pharm Sci 2006; 19: 62-5
  6. Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002: 26: 1159-64
  7. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 2006; 30: 400-18
  8. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316: 129-39
  9. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-56
  10. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab 2004; 30: 13-9
  11. Kılıç T. Is leptin an independent risk factor for development of left ventricular hypertrophy in obese hypertensive patients? Anadolu Kardiyol Derg 2008; 8: 347-9
  12. Dubey L, Hesong Z. Role of leptin in atherogenesis. Exp Clin Cardiol 2006; 11: 269-75
  13. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147: 173-80
  14. Satoh N, Naruse M, Usui T, Tagami T, Suganami T, Yamada K, et al. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 2004; 27: 2488-90
  15. Koebnick C, Shaibi GQ, Kelly LA, Roberts CK, Lane CJ, Toledo-Corral C, et al. Leptin-to-adiponectin ratio as independent predictor of insulin sensitivity during growth in overweight Hispanic youth. J Endocrinol Invest 2007; 30: RC13-6
  16. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-61
  17. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human e